Maxacalcitol

Star0

DB06272InvestigationalSmall molecule

Maxacalcitol: Overview.

Mechanism: Pharmacologically active on Vitamin D3 receptor
Curator reviewed
Formula / weight: C₂₆H₄₂O₄ · 418.6093 g/mol (avg)
Code names: SCH-209579

Resolves to

Compound

UNIIN2UJM5NBF6CAS103909-75-7ChEMBLCHEMBL333950ChEBI31801

Structure

InChIKeyDTXXSJZBSTYZKE-ZDQKKZTESA-NSMILES[H]\C(\C(\[H])=C1/CCC[C@@]2(C)[C@@]1([H])CC[C@]2([H])[C@]([H])(C)OCCC(C)(C)O)=C1/C[C@@]([H])(O)C[C@]([H])(O)C1=C

Targets

P11473VDR

What you can answer from here — as of July 03, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

195Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Maxacalcitol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account